Professional Overview
Lauren M. Huyett, PhD is a senior-level professional affiliated with Insulet Corporation, a Massachusetts-headquartered medical device company specializing in innovative insulin delivery systems. Her profile, based in San Diego, CA, is publicly documented on LinkedIn (over 500+ connections), where she is recognized for her extensive involvement in clinical research, biostatistics leadership, and medical writing related to insulin delivery technologies.
Educational Background
- PhD from University of California, Santa Barbara (UCSB), with a focus in Chemical Engineering.
- Recipient of the Best Oral Presentation Award from the UCSB Department of Chemical Engineering in October 2015.
Her academic credentials underpin a strong technical and scientific foundation relevant to biomedical and clinical engineering disciplines.
Role and Contributions at Insulet Corporation
Within Insulet, Lauren Huyett plays an instrumental role in advancing the clinical and biostatistical dimensions of the company's flagship products, most notably the Omnipod® systems, which represent a line of tubeless, wearable insulin pumps designed for continuous insulin delivery.
- She is actively involved in clinical affairs, with particular expertise in biostatistics; in 2025, she was publicly noted as seeking to expand her team to lead biostatistical functions at Insulet, signifying senior managerial and strategic responsibilities in clinical study design and data analysis.
- Provides technical advising and manuscript development on clinical research related to Omnipod insulin delivery systems, contributing to scientific publications and presentations.
- Recognized as an author or contributor in at least 72 research works with 1,674 citations, demonstrating sustained academic and clinical research engagement.
- Regularly participates in major conferences, including the American Diabetes Association Scientific Sessions and the European Association for the Study of Diabetes (EASD), contributing oral presentations and poster sessions showcasing clinical outcomes and psychosocial impacts related to Omnipod technologies.
Research and Publications
Lauren Huyett’s scientific outputs focus primarily on:
- The efficacy and psychosocial outcomes of the Omnipod 5 Automated Insulin Delivery (AID) System, particularly in populations ranging from very young children to adults with Type 1 and Type 2 diabetes.
- Studies reporting glycemic control improvements, reduced insulin delivery requirements related to physical activity, and patient satisfaction with tubeless insulin pump systems.
- Contributions to cost-effectiveness analyses of tubeless automated insulin delivery systems versus standard insulin delivery care.
- Active collaborator in real-world evidence studies evaluating transitions from multiple daily injections to automated insulin delivery with Omnipod.
Key recent publications include:
- “Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise” (2025).
- Psychosocial outcomes studies among caregivers of very young children using Omnipod 5.
- Real-World Glycemic Outcomes in adult Type 2 diabetes populations engaging with Omnipod systems.
Her work is published across leading journals such as Diabetes Care, Diabetes Technology & Therapeutics, and Journal of Managed Care & Specialty Pharmacy, and is frequently cited in clinical trial reports and cost-effectiveness studies supported by Insulet.
Technical and Professional Skills
Lauren’s skill set encompasses:
- Biostatistics and clinical research design
- Data analysis with tools including Matlab and Microsoft Excel
- Medical and scientific writing, peer-reviewed publications, and conference presentations
- Knowledge of insulin management systems, particularly automated and tubeless pumps
- Collaborative work with cross-functional teams, including clinical affairs, product development, and regulatory stakeholders.
Significance within Insulet Corporation
- Lauren’s leadership in biostatistics and clinical research is critical to Insulet’s strategic innovation pipeline, particularly as the company positions the Omnipod system as the #1 prescribed Automated Insulin Delivery (AID) system in the U.S., serving over 500,000 customers globally.
- Her role helps underpin the clinical data and scientific validation supporting Insulet’s product launches and regulatory submissions internationally.
- The combination of her deep technical background and active research profile supports Insulet’s mission to simplify and improve the lives of people with diabetes through technology.
Insulet Corporation Context (Relevant for Understanding Lauren’s Environment)
- Insulet reported $2.1 billion in revenue for 2024, with Omnipod products available in 25 countries worldwide.
- The Omnipod system is distinguished as a wearable, waterproof tubeless insulin pump (IP28 rating), offering freedom from multiple daily injections and integrating cloud-connected features.
- Insulet maintains a strong innovation emphasis, continuously enhancing product usability, connectivity, and clinical effectiveness.
This detailed profile encapsulates Lauren Huyett’s academic qualifications, clinical research leadership, and technical expertise within Insulet Corporation, underlining her pivotal role in generating and disseminating clinical evidence that supports Omnipod’s market position and ongoing product innovation efforts.
